US FDA approved Paxlovid for mild COVID-19 patients within 5 days. This drug has significant interactiion with many drugs. Severe case are treated with Remdesivir with other medication and oxygen.
US FDA approved Paxlovid for mild COVID-19 patients within 5 days. This drug has significant interactiion with many drugs. Severe case are treated with Remdesivir with other medication and oxygen.
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2024 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy